イスピネシブ(336113-53-2)

ChemicalBook Optimization Suppliers
名前: Zhengzhou HSH Science & Technology Co., Ltd.  Gold
電話番号: 0371-55932928 18937192232
電子メール: 1282296214@qq.com
名前: Shanghai Boyle Chemical Co., Ltd.  
電話番号:
電子メール: sales@boylechem.com
名前: J & K SCIENTIFIC LTD.  
電話番号: 010-82848833 400-666-7788
電子メール: jkinfo@jkchemical.com
名前: Chembest Research Laboratories Limited  
電話番号: 021-20908456
電子メール: sales@BioChemBest.com
名前: Chemsky (shanghai) International Co.,Ltd  
電話番号: 021-50135380
電子メール: shchemsky@sina.com
イスピネシブ 製品概要
化学名:イスピネシブ
英語化学名:Ispinesib
别名:Ispinesib;N-(3-Aminopropyl)-N-[(1R)-1-[7-chloro-3,4-dihydro-4-oxo-3-(phenylmethyl)-2-quinazolinyl]-2-methylpropyl]-4-methylbenzamide;SB 715992;Benzamide, N-(3-aminopropyl)-N-((1R)-1-(7-chloro-3,4-dihydro-4-oxo-3-(phenylmethyl)-2-quinazolinyl)-2-methylpropyl)-4-methyl-;Unii-bkt5F9C2ni;Ispinesib2;SB-71599;Ispinesib (SB-715992 /CK0238273)
CAS番号:336113-53-2
分子式:C30H33ClN4O2
分子量:517.06
EINECS:
カテゴリ情報:Chiral Reagents;Inhibitors;Intermediates & Fine Chemicals;Pharmaceuticals;Apis
Mol File:336113-53-2.mol
イスピネシブ
イスピネシブ 物理性質
融点 89 - 92°C
沸点 708.0±70.0 °C(Predicted)
比重(密度) 1.21±0.1 g/cm3(Predicted)
貯蔵温度 -20°C Freezer, Under inert atmosphere
溶解性Chloroform (Slightly), Methanol (Slightly)
外見 Solid
酸解離定数(Pka)9.65±0.10(Predicted)
White to Off-White
安全性情報
MSDS Information
イスピネシブ Usage And Synthesis
使用The kinesin-like spindle protein Eg5 (also known as kinesin-5, kinesin family protein 11, or Kif11) is a motor protein that is essential for establishing a bipolar spindle during mitosis both in normal and tumor cells. Ispinesib is a cell-permeable, allosteric inhibitor of Eg5 (Ki app = 2.3 nM) with >10,000-fold selectivity for Eg5 over a range of other mitotic kinesins. It induces a monopolar spindle phenotype, leading to the activation of a spindle assembly checkpoint, mitotic arrest, and subsequent cell death (GI50s = 22-82 nM in colon, pancreas, prostrate, and lung cancer cells in vitro). At 10 mg/kg, ispinesib produces tumor regression of breast cancer cell xenografts in mice. It has also been used to halt the growth of treatment-resistant glioblastoma tumor-initiating cells, to prevent tumor initiation and self-renewal of a cancer stem cell population (EC50 = 1.15 nM), and to reduce glioma cell invasion.[Cayman Chemical]
定義ChEBI: N-(3-aminopropyl)-N-[(1R)-1-[7-chloro-4-oxo-3-(phenylmethyl)-2-quinazolinyl]-2-methylpropyl]-4-methylbenzamide is a member of benzamides.
生物活性ispinesib (sb-715992) is a selective inhibitor of ksp with ic50 value of 0.5 nm [1].kinesin spindle protein (ksp) is a kinesin motor protein and plays an important role in the formation of a bipolar mitotic spindle and cell cycle progression through mitosis. it has been shown that abnormal expression of ksp is correlated with a variety of human cancers and its inhibitors may be a promising anticancer agent [2] [3].ispinesib (sb-715992) is a potent ksp inhibitor and often combines with chemotherapy drugs to tumor treatment. when tested with a panel of 23 tumor cell lines, ispinesib (sb-715992) treatment showed high activity to inhibit ksp in most of the cell lines while only rh18 having an ic50 value greater than 1 μm (median ic50=4.1 nm, maximum ic50=0.5 nm) by using pptp method [1]. in a panel of 53 breast cell lines, ispinesib (sb-715992) exhibits broad antiproliferative activity and up-regulated the expression of both mitotic and apoptotic markers in mda-mb-468 cell line [2]. when tested with pc-3 cells, ispinesib (sb-715992) treatment inhibits cell proliferation, inducs cell apoptosis and up-regulated the expressions of genes that related to the control of cell proliferation, cell cycle, cell signaling pathways and apoptosis [3].in mouse model with 26 tumor cells subcutaneous xenograft, administration of ispinesib (sb-715992) inducs markedly tumor growth delay with the percent of 88% (23/26) and maintained completed response (cr) in the rhaboid tumor, wilms tumor and ewing sarcoma xenograft mouse model [1].
貯蔵Store at -20°C
参考文献[1]. carol, h., et al., initial testing (stage 1) of the kinesin spindle protein inhibitor ispinesib by the pediatric preclinical testing program. pediatr blood cancer, 2009. 53(7): p. 1255-63.
[2]. purcell, j.w., et al., activity of the kinesin spindle protein inhibitor ispinesib (sb-715992) in models of breast cancer. clin cancer res, 2010. 16(2): p. 566-76.
[3]. davis, d.a., et al., increased therapeutic potential of an experimental anti-mitotic inhibitor sb715992 by genistein in pc-3 human prostate cancer cell line. bmc cancer, 2006. 6: p. 22.
Tags:336113-53-2